Amy Ford

2.8k total citations · 1 hit paper
7 papers, 2.4k citations indexed

About

Amy Ford is a scholar working on Molecular Biology, Oncology and Clinical Biochemistry. According to data from OpenAlex, Amy Ford has authored 7 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Clinical Biochemistry. Recurrent topics in Amy Ford's work include Fibroblast Growth Factor Research (2 papers), Kruppel-like factors research (2 papers) and Cancer therapeutics and mechanisms (1 paper). Amy Ford is often cited by papers focused on Fibroblast Growth Factor Research (2 papers), Kruppel-like factors research (2 papers) and Cancer therapeutics and mechanisms (1 paper). Amy Ford collaborates with scholars based in United States and United Kingdom. Amy Ford's co-authors include S. Richard Jaskunas, Alexei Kharitonenkov, Anja Köester, Victor J. Wroblewski, Radmila Micanovic, Tatiyana L. Shiyanova, Elizabeth J. Galbreath, Jesper Gromada, Lisa J. Hammond and Eric D. Hawkins and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Endocrinology.

In The Last Decade

Amy Ford

7 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FGF-21 as a novel metabolic regulator

2005 1.8k citations Alexei Kharitonenkov, Tatiyana L. Shiyanova et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy Ford United States	6	1.6k	429	399	380	332	7	2.4k
Rosa Di Paola Italy	21	682 0.4×	538 1.3×	261 0.7×	641 1.7×	341 1.0×	64	1.8k
Holly A. Bina United States	16	2.9k 1.8×	699 1.6×	131 0.3×	492 1.3×	245 0.7×	16	3.7k
Sabrina Prudente Italy	24	825 0.5×	372 0.9×	194 0.5×	284 0.7×	430 1.3×	69	1.8k
Joshua E. Basford United States	19	479 0.3×	314 0.7×	265 0.7×	344 0.9×	171 0.5×	22	1.2k
Elisabetta Trabetti Italy	29	430 0.3×	387 0.9×	490 1.2×	223 0.6×	449 1.4×	66	2.3k
Hisashi Makino Japan	27	634 0.4×	232 0.5×	509 1.3×	171 0.5×	417 1.3×	63	1.9k
Yusuke Nakagawa Japan	21	501 0.3×	261 0.6×	573 1.4×	117 0.3×	272 0.8×	86	1.7k
Carl G. Brewer Canada	8	1.1k 0.7×	470 1.1×	106 0.3×	294 0.8×	269 0.8×	9	1.9k
Winfried Maerz Germany	22	387 0.2×	247 0.6×	704 1.8×	352 0.9×	438 1.3×	45	1.9k
Frank Pistrosch Germany	24	639 0.4×	291 0.7×	461 1.2×	112 0.3×	582 1.8×	44	1.7k

Countries citing papers authored by Amy Ford

Since Specialization

Citations

This map shows the geographic impact of Amy Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Ford more than expected).

Fields of papers citing papers by Amy Ford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Ford. The network helps show where Amy Ford may publish in the future.

Co-authorship network of co-authors of Amy Ford

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Ford. A scholar is included among the top collaborators of Amy Ford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Ford. Amy Ford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Lee, Siow Ming, Madeleine Hewish, Samreen Ahmed, et al.. (2024). Hydroxychloroquine in combination with platinum doublet chemotherapy as first-line treatment for extensive-stage small cell lung cancer (Study 15): A randomised phase II multicentre trial. European Journal of Cancer. 215. 115162–115162. 3 indexed citations

2.

Ford, Amy & Ernie Marshall. (2014). Neutropenic sepsis: a potentially life-threatening complication of chemotherapy. Clinical Medicine. 14(5). 538–542. 5 indexed citations

3.

Kharitonenkov, Alexei, John M. Beals, Radmila Micanovic, et al.. (2013). Rational Design of a Fibroblast Growth Factor 21-Based Clinical Candidate, LY2405319. PLoS ONE. 8(3). e58575–e58575. 146 indexed citations

4.

Stavraka, Chara, Amy Ford, Sadaf Ghaem‐Maghami, et al.. (2011). A study of symptoms described by ovarian cancer survivors. Gynecologic Oncology. 125(1). 59–64. 69 indexed citations

5.

Köster, Anja, Ye Chao, Marian Mosior, et al.. (2005). Transgenic Angiopoietin-Like (Angptl)4 Overexpression and Targeted Disruption of Angptl4 and Angptl3: Regulation of Triglyceride Metabolism. Endocrinology. 146(11). 4943–4950. 362 indexed citations

6.

Kharitonenkov, Alexei, Tatiyana L. Shiyanova, Anja Köester, et al.. (2005). FGF-21 as a novel metabolic regulator. Journal of Clinical Investigation. 115(6). 1627–1635. 1750 indexed citations breakdown →

7.

Heuer, Josef G., et al.. (2004). Cecal ligation and puncture with total parenteral nutrition: A clinically relevant model of the metabolic, hormonal, and inflammatory dysfunction associated with critical illness. Journal of Surgical Research. 121(2). 178–186. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact